Precision medicine aspires to revolutionize healthcare by using novel biomarkers to individualize patient treatments and ensure that patients receive the most effective drugs the first time. This methodology aims to avoid the current trial-and-error approach to patient care. In this webinar, we review recent precision medicine studies in lupus and rheumatoid arthritis and discuss new advances in biomarker research for patient stratification.

Featured Speaker:

Dr. Myles Lewis PhD, FRCP

Reader in Rheumatology

Queen Mary University of London